ALKERMES | ALKS - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
AbbVie USD 14.39B 1.85B 2026-06
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
ALKERMES USD 375.31M 43.98M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 6.8B 1.29B 2026-06
Heron Therapeutics USD 29.47M 3.17M 2025-12
Ionis Pharmaceuticals USD 265M 22M 2026-06
J&J USD 18.55B 1.31B 2026-06
Merck USD 12.09B 1.24B 2026-03
Minerva Neurosciences -4.27M 26.79M 2024-12
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Otsuka Holdings JPY 456.25B 1.16B 2026-03
Pfizer USD -248M 11.29B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06